Deep vein thrombosis landmark trials in treatment: Revision history

13 July 2014

• curprev 12:0412:04, 13 July 2014‎ Rim Halaby talk contribs‎ 19,251 bytes +236‎ No edit summary

31 July 2013

• curprev 14:3614:36, 31 July 2013‎ Gonzalo Romero talk contribs‎ 19,015 bytes +265‎ →‎Use of IVC filters
• curprev 14:2314:23, 31 July 2013‎ Gonzalo Romero talk contribs‎ 18,750 bytes +32‎ →‎Use of IVC filters
• curprev 14:2214:22, 31 July 2013‎ Gonzalo Romero talk contribs‎ 18,718 bytes +380‎ →‎Use of IVC filters
• curprev 14:1714:17, 31 July 2013‎ Gonzalo Romero talk contribs‎ 18,338 bytes +1‎ →‎Use of IVC filters
• curprev 14:1714:17, 31 July 2013‎ Gonzalo Romero talk contribs‎ 18,337 bytes +109‎ →‎Use of IVC filters
• curprev 14:1414:14, 31 July 2013‎ Gonzalo Romero talk contribs‎ 18,228 bytes +1,352‎ →‎Use of IVC filters
• curprev 14:0114:01, 31 July 2013‎ Gonzalo Romero talk contribs‎ 16,876 bytes +256‎ →‎Use of IVC filters

31 January 2013

• curprev 16:5116:51, 31 January 2013‎ Vishnu Vardhan Serla talk contribs‎ 16,620 bytes −2‎ →‎Newer anticoagulants

29 January 2013

• curprev 21:5321:53, 29 January 2013‎ Vishnu Vardhan Serla talk contribs‎ 16,622 bytes −57‎ →‎Trials Comparing Different Formulations of Heparin in the Treatment of DVT

28 January 2013

• curprev 19:1619:16, 28 January 2013‎ Vishnu Vardhan Serla talk contribs‎ 16,679 bytes +110‎ No edit summary
• curprev 19:1619:16, 28 January 2013‎ Vishnu Vardhan Serla talk contribs‎ 16,569 bytes +10‎ No edit summary

1 November 2012

• curprev 15:5415:54, 1 November 2012‎ WikiBot talk contribs‎ m 16,559 bytes +11‎ Robot: Automated text replacement (-mgibson@perfuse.org +charlesmichaelgibson@gmail.com & -kfeeney@perfuse.org +kfeeney@elon.edu)

21 June 2012

• curprev 01:1801:18, 21 June 2012‎ C Michael Gibson talk contribs‎ m 16,548 bytes 0‎ moved Deep vein thrombosis landmark trials to Deep vein thrombosis landmark trials in treatment
• curprev 01:1701:17, 21 June 2012‎ C Michael Gibson talk contribs‎ 16,548 bytes −2,154‎ /* RECORD 2 Study{{cite journal |author=Lassen MR, Ageno W, Borris LC, et al. |title=Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty |journal=N. Engl. J. Med. |volume=358 |issue=26 |pages=2776–86 |year=2008 |mo...
• curprev 01:1601:16, 21 June 2012‎ C Michael Gibson talk contribs‎ 18,702 bytes −2,390‎ /* RECORD 1 Study{{cite journal |author=Eriksson BI, Borris LC, Friedman RJ, et al. |title=Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty |journal=N. Engl. J. Med. |volume=358 |issue=26 |pages=2765–75 |year=2008 |mon...
• curprev 01:1501:15, 21 June 2012‎ C Michael Gibson talk contribs‎ 21,092 bytes −2,436‎ /* RECORD 3 Study{{cite journal |author=Kakkar AK, Brenner B, Dahl OE, et al. |title=Extended duration rivaroxaban versus short-term enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a double-blind, randomised c...
• curprev 00:5300:53, 21 June 2012‎ Justine Cadet talk contribs‎ 23,528 bytes −1‎ /* RECORD 3 Study{{cite journal |author=Kakkar AK, Brenner B, Dahl OE, et al. |title=Extended duration rivaroxaban versus short-term enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a double-blind, randomised c...
• curprev 00:5200:52, 21 June 2012‎ Justine Cadet talk contribs‎ 23,529 bytes −61‎ /* RECORD 3{{cite journal |author=Kakkar AK, Brenner B, Dahl OE, et al. |title=Extended duration rivaroxaban versus short-term enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a double-blind, randomised control...
• curprev 00:5100:51, 21 June 2012‎ Justine Cadet talk contribs‎ 23,590 bytes +2,500‎ /* RECORD 2 Study{{cite journal |author=Lassen MR, Ageno W, Borris LC, et al. |title=Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty |journal=N. Engl. J. Med. |volume=358 |issue=26 |pages=2776–86 |year=2008 |mo...
• curprev 00:4500:45, 21 June 2012‎ Justine Cadet talk contribs‎ 21,090 bytes +2,151‎ /* RECORD 1 Study{{cite journal |author=Eriksson BI, Borris LC, Friedman RJ, et al. |title=Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty |journal=N. Engl. J. Med. |volume=358 |issue=26 |pages=2765–75 |year=2008 |mon...
• curprev 00:3700:37, 21 June 2012‎ Justine Cadet talk contribs‎ 18,939 bytes +3‎ /* RECORD 1 Study{{cite journal |author=Eriksson BI, Borris LC, Friedman RJ, et al. |title=Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty |journal=N. Engl. J. Med. |volume=358 |issue=26 |pages=2765–75 |year=2008 |mon...
• curprev 00:3400:34, 21 June 2012‎ Justine Cadet talk contribs‎ 18,936 bytes −1‎ /* =RECORD 1 Study{{cite journal |author=Eriksson BI, Borris LC, Friedman RJ, et al. |title=Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty |journal=N. Engl. J. Med. |volume=358 |issue=26 |pages=2765–75 |year=2008 |mo...
• curprev 00:3300:33, 21 June 2012‎ Justine Cadet talk contribs‎ 18,937 bytes +1‎ /* =RECORD 1 Study{{cite journal |author=Eriksson BI, Borris LC, Friedman RJ, et al. |title=Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty |journal=N. Engl. J. Med. |volume=358 |issue=26 |pages=2765–75 |year=2008 |mo...
• curprev 00:3200:32, 21 June 2012‎ Justine Cadet talk contribs‎ 18,936 bytes +11‎ /* =RECORD 1 Study{{cite journal |author=Eriksson BI, Borris LC, Friedman RJ, et al. |title=Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty |journal=N. Engl. J. Med. |volume=358 |issue=26 |pages=2765–75 |year=2008 |mo...
• curprev 00:3000:30, 21 June 2012‎ Justine Cadet talk contribs‎ 18,925 bytes +2,377‎ /* EINSTEIN Study{{cite journal |author=Bauersachs R, Berkowitz SD, Brenner B, et al. |title=Oral rivaroxaban for symptomatic venous thromboembolism |journal=N. Engl. J. Med. |volume=363 |issue=26 |pages=2499–510 |year=2010 |month=December |pmid...

14 June 2012

• curprev 18:4518:45, 14 June 2012‎ C Michael Gibson talk contribs‎ 16,548 bytes +66‎ /* EINSTEIN Study{{cite journal |author=Bauersachs R, Berkowitz SD, Brenner B, et al. |title=Oral rivaroxaban for symptomatic venous thromboembolism |journal=N. Engl. J. Med. |volume=363 |issue=26 |pages=2499–510 |year=2010 |month=December |pmid...
• curprev 18:3118:31, 14 June 2012‎ C Michael Gibson talk contribs‎ 16,482 bytes +51‎ →‎Use of IVC filters
• curprev 18:2618:26, 14 June 2012‎ C Michael Gibson talk contribs‎ 16,431 bytes +9‎ →‎Use of IVC filters
• curprev 18:1718:17, 14 June 2012‎ C Michael Gibson talk contribs‎ 16,422 bytes +6‎ →‎Use of IVC filters
• curprev 18:1518:15, 14 June 2012‎ C Michael Gibson talk contribs‎ 16,416 bytes +36‎ /* Meta-Analysis Evaluating Thrombolysis{{cite journal |author=Watson LI, Armon MP |title=Thrombolysis for acute deep vein thrombosis |journal=Cochrane Database Syst Rev |volume= |issue=4 |pages=CD002783 |year=2004 |pmid=15495034 |doi=10.1002/1465...
• curprev 18:1318:13, 14 June 2012‎ C Michael Gibson talk contribs‎ 16,380 bytes 0‎ /* Catheter-directed thrombolysis{{cite journal |author=Enden T, Kløw NE, Sandvik L, et al. |title=Catheter-directed thrombolysis vs. anticoagulant therapy alone in deep vein thrombosis: results of an open randomized, controlled trial reporting o...
• curprev 18:1318:13, 14 June 2012‎ C Michael Gibson talk contribs‎ 16,380 bytes +2‎ /* Meta-analysis assessing Thromblysis{{cite journal |author=Watson LI, Armon MP |title=Thrombolysis for acute deep vein thrombosis |journal=Cochrane Database Syst Rev |volume= |issue=4 |pages=CD002783 |year=2004 |pmid=15495034 |doi=10.1002/146518...
• curprev 18:1118:11, 14 June 2012‎ C Michael Gibson talk contribs‎ 16,378 bytes +4‎ /* Catheter-directed thrombolysis{{cite journal |author=Enden T, Kløw NE, Sandvik L, et al. |title=Catheter-directed thrombolysis vs. anticoagulant therapy alone in deep vein thrombosis: results of an open randomized, controlled trial reporting o...
• curprev 18:0918:09, 14 June 2012‎ C Michael Gibson talk contribs‎ 16,374 bytes +58‎ /* Catheter-directed thrombolysis{{cite journal |author=Enden T, Kløw NE, Sandvik L, et al. |title=Catheter-directed thrombolysis vs. anticoagulant therapy alone in deep vein thrombosis: results of an open randomized, controlled trial reporting o...
• curprev 18:0518:05, 14 June 2012‎ Kristin Feeney talk contribs‎ 16,316 bytes +316‎ No edit summary
• curprev 18:0318:03, 14 June 2012‎ C Michael Gibson talk contribs‎ 16,000 bytes +24‎ /* Meta-Analysis of Home Versus Inpatient Treatment of DVT{{cite journal |author=Schraibman IG, Milne AA, Royle EM |title=Home versus in-patient treatment for deep vein thrombosis |journal=Cochrane Database Syst Rev |volume= |issue=2 |pages=CD0030...
• curprev 18:0218:02, 14 June 2012‎ C Michael Gibson talk contribs‎ 15,976 bytes +51‎ /* Meta-Analysis of Home Versus Inpatient Treatment of DVT{{cite journal |author=Schraibman IG, Milne AA, Royle EM |title=Home versus in-patient treatment for deep vein thrombosis |journal=Cochrane Database Syst Rev |volume= |issue=2 |pages=CD0030...
• curprev 17:5617:56, 14 June 2012‎ C Michael Gibson talk contribs‎ 15,925 bytes 0‎ /* Meta-analysis of Home versus inpatient treatment of DVT{{cite journal |author=Schraibman IG, Milne AA, Royle EM |title=Home versus in-patient treatment for deep vein thrombosis |journal=Cochrane Database Syst Rev |volume= |issue=2 |pages=CD0030...
• curprev 17:5617:56, 14 June 2012‎ C Michael Gibson talk contribs‎ 15,925 bytes +5‎ /* Meta-Analysis Evaluating LMWH Dosing{{cite journal |author=van Dongen CJ, MacGillavry MR, Prins MH |title=Once versus twice daily LMWH for the initial treatment of venous thromboembolism |journal=Cochrane Database Syst Rev |volume= |issue=3 |pa...
• curprev 17:5517:55, 14 June 2012‎ C Michael Gibson talk contribs‎ 15,920 bytes +1‎ /* Meta-analysis assessing LMWH dosing{{cite journal |author=van Dongen CJ, MacGillavry MR, Prins MH |title=Once versus twice daily LMWH for the initial treatment of venous thromboembolism |journal=Cochrane Database Syst Rev |volume= |issue=3 |pag...
• curprev 17:5417:54, 14 June 2012‎ C Michael Gibson talk contribs‎ 15,919 bytes +5‎ →‎Trials Evaluating Fondaparinux
• curprev 17:4317:43, 14 June 2012‎ C Michael Gibson talk contribs‎ 15,914 bytes +2‎ →‎Trials Evaluating Fondaparinux
• curprev 17:4217:42, 14 June 2012‎ C Michael Gibson talk contribs‎ 15,912 bytes −3‎ →‎Trials regarding the use of Fondaprinux
• curprev 17:4117:41, 14 June 2012‎ C Michael Gibson talk contribs‎ 15,915 bytes +5‎ →‎Trials Comparing Low-Molecular-Weight Heparin With Intravenous Unfractionated Heparin
• curprev 17:4017:40, 14 June 2012‎ C Michael Gibson talk contribs‎ 15,910 bytes −1,254‎ →‎Trials Comparing Low-Molecular-Weight Heparin With Intravenous Unfractionated Heparin
• curprev 17:3917:39, 14 June 2012‎ C Michael Gibson talk contribs‎ 17,164 bytes +6‎ →‎Trials Comparing Low-Molecular-Weight Heparin With Intravenous Unfractionated Heparin
• curprev 17:3817:38, 14 June 2012‎ C Michael Gibson talk contribs‎ 17,158 bytes +6‎ →‎Trials Comparing Low-Molecular-Weight Heparin With Intravenous Unfractionated Heparin
• curprev 17:3717:37, 14 June 2012‎ C Michael Gibson talk contribs‎ 17,152 bytes 0‎ →‎Trials comparing Low-molecular-weight Heparin With intravenous unfractionated Heparin
• curprev 17:3717:37, 14 June 2012‎ C Michael Gibson talk contribs‎ 17,152 bytes 0‎ →‎Trials Comparing Low-molecular-weight Heparin With subcutaneous unfractionated Heparin